MX9305713A - Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv. - Google Patents

Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv.

Info

Publication number
MX9305713A
MX9305713A MX9305713A MX9305713A MX9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A MX 9305713 A MX9305713 A MX 9305713A
Authority
MX
Mexico
Prior art keywords
immunocompetence
hiv
restoration
patients infected
auxiliary cells
Prior art date
Application number
MX9305713A
Other languages
English (en)
Spanish (es)
Inventor
Mario Clerici
Robert L Coffman
Gene M Shearer
Original Assignee
Schering Corp
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp, Us Health filed Critical Schering Corp
Publication of MX9305713A publication Critical patent/MX9305713A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5428—IL-10

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9305713A 1992-09-18 1993-09-17 Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv. MX9305713A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94731692A 1992-09-18 1992-09-18

Publications (1)

Publication Number Publication Date
MX9305713A true MX9305713A (es) 1994-05-31

Family

ID=25485948

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305713A MX9305713A (es) 1992-09-18 1993-09-17 Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv.

Country Status (6)

Country Link
EP (1) EP0667789A1 (fr)
JP (1) JPH08501549A (fr)
AU (1) AU4856793A (fr)
CA (1) CA2144648A1 (fr)
MX (1) MX9305713A (fr)
WO (1) WO1994006473A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19529026C2 (de) * 1995-07-28 1997-06-19 Robert Sabat Monoklonale Antikörper gegen humanes Interleukin-10
WO1998010792A1 (fr) * 1996-09-11 1998-03-19 Prendergast Patrick T Therapie a but immunitaire
DE19939653A1 (de) * 1999-08-13 2001-02-22 Thomas Huenig Verwendung CD28 spezifischer monoklonaler Antikörper zur Herstellung einer pharmazeutischen Zusammensetzung
DE60138222D1 (de) 2000-09-14 2009-05-14 Beth Israel Hospital Modulierung von il-2 und il-15 vermittelten t zellantworten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
CZ281796B6 (cs) * 1991-08-06 1997-02-12 Schering Corporation Použití interleukinu-10, jeho analoga, agonisty nebo antagonisty pro výrobu léčiva a farmaceutický přípravek je obsahující

Also Published As

Publication number Publication date
JPH08501549A (ja) 1996-02-20
AU4856793A (en) 1994-04-12
EP0667789A1 (fr) 1995-08-23
WO1994006473A1 (fr) 1994-03-31
CA2144648A1 (fr) 1994-03-31

Similar Documents

Publication Publication Date Title
ES2138086T3 (es) Constructo de peptido sintetico compuesto que provoca anticuerpos neutralizantes y linfocitos t citotoxicos contra hiv.
MX9304837A (es) Peptidos capaces de inhibir la actividad de proteasa vih, su preparacion y su uso terapeutico.
IT8603530A0 (it) Membrana per uso farmaceutico ed industriale
ES2118835T3 (es) 2-etil-1h-imidazo(4,5-c)quinolin-4-aminas antiviricas.
DE3751682D1 (de) Infektiöses System zur Arzneimittelabgabe
ES2075050T3 (es) Peptidos que tienen actividad cooperadora de celulas t.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
ES2172764T3 (es) Modulacion de la expresion de citoquina th1/th2 por ribavirina en linfocitos t activados.
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
ES2108969T3 (es) Utilizacion de analogos de didesoxinucleosidos en el tratamiento de infecciones virales.
ES2167457T3 (es) Nuevo uso medicinal de un antagonista de 5ht3.
ES2134197T3 (es) Vacunas contra el virus del herpes simplex vp16.
CO4940406A1 (es) Composiciones de paracetamol de accion rapida
MX9305713A (es) Restablecimiento de inmunocompetencia a celulas auxiliares t en pacientes infectados co hiv.
MX9303572A (es) Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.
IT1106143B (it) Peptidi e loro derivati per uso farmaceutico e procedimento per la preparazione delle formulazioni che li contengono
ES2103493T3 (es) Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo.
ES2111163T3 (es) Uso de fosfonatos para el tratamiento de la osteoporosis.
UY27662A1 (es) Inhibidores de la mocroglia para interrumpir reacciones inmunes asociadas con interleucina 12 y ifny.
ES2147453T3 (es) Antagonistas de adenosina, procedimiento para su preparacion y su uso como medicamentos.
ES2137153T3 (es) Uso de la prostaglandina e1 para curar la impotencia erectil masculina.
MX9307733A (es) Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
DK0614372T3 (da) Antiviral faktor fra CD8+-celler
ES2131815T3 (es) Diesteres de acido carbonico dotados de actividad antiviral y antiinflamatoria.